Pulmonx (LUNG) Stock Statistics & Valuation Metrics

Pulmonx has a market cap or net worth of $56.18M. The enterprise value is $42.53M.

Pulmonx has 42,237,200 shares outstanding. The number of shares has decreased by -2.65% in one year.

Pulmonx’s return on equity (ROE) is -1.00 and return on invested capital (ROIC) is -48.54%.

The current PE Ratio of Pulmonx is ―. Pulmonx’s PEG ratio is 0.22.

In the last 12 months, Pulmonx had revenue of 90.50M and earned -54.00M in profits. Earnings per share was -1.33.

In the last 12 months, operating cash flow was -32.42M and capital expenditures -452.00K, giving a free cash flow of -32.87M billion.

Pulmonx pays an annual dividend of ―, resulting in a dividend yield of ―

Pulmonx upcoming earnings date is May 5, 2026, After Close (Confirmed).

Pulmonx as a current ratio of 5.07, with Debt / Equity ratio of 104.15%

In the past 12 months, Pulmonx has paid 626.00K in taxes.

Pulmonx EV to EBITDA ratio is -1.45, with an EV/FCF ratio of -2.32.

Pulmonx has $70.01M in cash and marketable securities with $56.36M in debt, giving a net cash position of $13.64M billion.

Gross margin is 74.19%, with operating margin of -59.30%, and net profit margin of -59.67%.

The average price target for Pulmonx is $3.83, which is 11.43% higher than the current price. The consensus rating is Moderate Buy